Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.4.381

Pathological Factors Affecting DNA Quality in BRAF, EGFR, and KRAS Gene Molecular Tests  

Yun, Hyon-Goo (Department of Pathology, Kangbuk Samsung Hospital)
Kim, Bo-Ra (Department of Pathology, Kangbuk Samsung Hospital)
Lee, Joo-Mi (Department of Pathology, Kangbuk Samsung Hospital)
Song, Eun-Ha (Department of Pathology, Kangbuk Samsung Hospital)
Kim, Dong-Hoon (Department of Pathology, Kangbuk Samsung Hospital)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.4, 2020 , pp. 381-388 More about this Journal
Abstract
The quality control of pathological specimens is important for accurate molecular pathology testing. This study evaluated that specimen factors affecting the DNA quality during tissue processing and sample types for BRAF, EGFR, and KRAS mutations tests. One thousand seven hundred and seventy-two molecular pathology tests were investigated for the factors influencing the DNA quality, such as sample type, formalin fixation time, and reexamination status. Cytology samples stored in a saline solution had better DNA quality than commercial cytology preservation. Tissue samples fixed in formalin within 24 hours had better DNA quality than the samples fixed over 24 hours. Between the types of samples, fresh tissue samples and tissue samples with a high tumor cell density had relatively better DNA quality than the formalin-fixed paraffin-embedded (FFPE) tissues and cytology specimens. Of real-time PCR, the non-PNA Ct value increased proportionally with samples held for longer than 24 hours in formalin, and that the formalin-fixed time affects the sample DNA quality. In conclusion, the appropriate tumor cellularity and 10% neutral formalin fixation time are the most important factors for maintaining the DNA quality. These factors should be managed properly for an accurate pathological molecular test to ensure optimal DNA quality.
Keywords
DNA; Formalin fixation; Molecular test; Quality control;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjo A, Rouleau E, et.al. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014;67:923-931. https://doi.org/10.1136/jclinpath-2014-202404   DOI
2 Hunt JL. Molecular pathology in anatomic pathology practice: a review of basic principles. Arch Pathol Lab Med. 2008; 132:248-260. https://doi.org/10.1043/1543-2165(2008)132[248:MPIAPP]2.0.CO;2   DOI
3 Carithers LJ, Agarwal R, Guan P, Odeh H, Sachs MC, Engel KB, et al. The biospecimen preanalytical variables program: a multiassay comparison of effects of delay to fixation and fixation duration on nucleic acid quality. Arch Pathol Lab Med. 2019; 143:1106-1118. https://doi.org/10.5858/arpa.2018-0172-OA   DOI
4 Yun HG, Lee HJ, Kim BR, Lee JH, Lee JH, Kim K, et.al. Factors affecting KRAS mutation detection in colorectal cancer tissue. Pathol Res Pract. 2019;215:1071-1075. https://doi.org/10.1016/j.prp.2019.02.018.   DOI
5 Zhao J, Liu P, Yu Y, Zhi J, Zheng X, Yu J, et al. Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer. Oncol Lett. 2019;17:4661-4666. https://doi.org/10.3892/ol.2019.10131   DOI
6 Yatabe Y, Kerr KM, Utomo A, Rajadurai P, Tran VK, Du X, et al. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol. 2015;10:438-445. https://doi.org/10.1097/JTO.0000000000000422   DOI
7 Shackelford RE, Whitling NA, McNab P, Japa S, Coppola D. KRAS testing: a tool for the implementation of personalized medicine. Genes Cancer. 2012;3:459-466. https://doi.org/10.1177/1947601912460547   DOI
8 Prentice LM, Miller RR, Knaggs J, Mazloomian A, Aguirre Hernandez R, Franchini P, et al. Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice. PLoS One. 2018;13:e0196434. https://doi.org/10.1371/journal.pone.0196434   DOI
9 Taguchi M, Inoue H, Motani-Saitoh H, Yajima D, Hayakawa M, Otsuka K, et al. DNA identification of formalin-fixed organs is affected by fixation time and type of fixatives: using the AmpF l STR(R) Identifiler(R) PCR amplification kit. Med Sci Law. 2012;52:12-16. https://doi.org/10.1258/msl.2011.010140   DOI
10 Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, et al. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma. Mol Diagn Ther. 2014;18:409-418. https://doi.org/10.1007/s40291-014-0091-6   DOI